Rosamond Deegan

Rosamond Deegan serves as CEO at OMass Therapeutics. OMass Therapeutics operates in the research sector with approximately 87.0 employees. The company is headquartered in Oxford, England. OMass Therapeutics generates annual revenue of 503000.0. To date, OMass Therapeutics has raised 159256061.0 in total funding, with the most recent round being Series B.

Industry & Role Insights

• • MessageCEO tracks 2,961 executives in the research sector.
• • 10,137 executive contacts are available in England.
• • Our database includes 201,469 c suite-level executives.

ElasticEmail Outlook MailChimp SPF Microsoft Office 365 DigitalOcean Cloudways Workable reCAPTCHA Nginx MailChimp New Relic Google Maps (Non Paid Users) Google Analytics YouTube Mobile Friendly Google Maps WordPress.org Google Font API Google Tag Manager Remote

biotechnology research biotechnology drug discovery native mass spectrometry biochemistry orphan diseases immunological diseases soluble carriers gpcrs inflammasome complexes small molecule therapeutics membrane proteins cell-free methods drug interaction binding affinity therapeutic development therapeutic innovation patient-centered treatments target ecosystems clinical candidates high-resolution analysis biopharmaceuticals genetic association pathway linked patient selection high unmet need lead optimization pharmacology bioscience regulatory pathways drug targets innovative therapies biomolecule interactions bioengineering molecular pharmacology translational medicine precision medicine high fidelity measurements differentiated therapies drug efficacy structural biology multi-modal drug approaches therapeutics pipeline academic partnership science-driven venture capital protein complexes therapeutic candidates strategic investments cro therapeutic engineering biopharma collaboration

SN

Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.

SD

Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.

M

Mark Chief Executive Officer at 23Strands

IT

Ilia Tikhomirov Chief Executive Officer at 35Pharma

AD

Alistair Draffan Chief Executive Officer at 360biolabs Pty Ltd

Outreach Guidance — research Sector

Executives like Rosamond Deegan in the research sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at OMass Therapeutics.

How do I reach Rosamond Deegan directly?

Rosamond Deegan's verified email address is available to MessageCEO Pro subscribers. They currently serve as CEO at OMass Therapeutics. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Rosamond Deegan work for?

Rosamond Deegan is CEO at OMass Therapeutics, a company in the research sector with 87.0 employees. The company is based in Oxford, England.

Can I pitch or sell to Rosamond Deegan?

As CEO at OMass Therapeutics, Rosamond Deegan is a key decision-maker in the research sector. MessageCEO Pro gives you verified email to reach Rosamond Deegan directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Rosamond Deegan in?

Rosamond Deegan works in the research industry as CEO at OMass Therapeutics. MessageCEO provides verified contact information for executives across all major industries.

Is Rosamond Deegan's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Rosamond Deegan's profile is kept up-to-date with the latest available information.

Last updated: May 13, 2026